Search Ontology:
ChEBI
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor
- Term ID
- CHEBI:138927
- Synonyms
-
- 2-N-formyl-1-N-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitor
- 2-N-formyl-1-N-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitors
- 5'-phosphoribosylformylglycinamide:L-glutamine amido-ligase (ADP-forming) inhibitor
- 5'-phosphoribosylformylglycinamide:L-glutamine amido-ligase (ADP-forming) inhibitors
- EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitors
- EC 6.3.5.3 inhibitor
- EC 6.3.5.3 inhibitors
- FGAM synthase inhibitor
- FGAM synthase inhibitors
- FGAM synthetase inhibitor
- FGAM synthetase inhibitors
- FGAR amidotransferase inhibitor
- FGAR amidotransferase inhibitors
- FGARAT inhibitor
- FGARAT inhibitors
- formylglycinamide ribonucloetide amidotransferase inhibitor
- formylglycinamide ribonucloetide amidotransferase inhibitors
- formylglycinamide ribotide amidotransferase inhibitor
- formylglycinamide ribotide amidotransferase inhibitors
- N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitor
- N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitors
- phosphoribosylformylglycinamidine synthase inhibitor
- phosphoribosylformylglycinamidine synthase inhibitors
- phosphoribosylformylglycinamidine synthetase inhibitor
- phosphoribosylformylglycinamidine synthetase inhibitors
- phosphoribosylformylglycineamidine synthetase inhibitor
- phosphoribosylformylglycineamidine synthetase inhibitors
- Definition
- Any EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor that interferes with the action of phosphoribosylformylglycinamidine synthase (EC 6.3.5.3).
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- inverse has_role
-
Phenotype
Phenotype resulting from EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor
Phenotype where environments contain EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor
Phenotype modified by environments containing EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor
Human Disease Model